Evaluate Safety Simplicity News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Evaluate Safety Simplicity. Real-time updates on events, politics, business and more.

David Fleischer, MD: Phase 3 Trial on Peanut Immunotherapy Patch

April 17, 2023

In his interview, Fleischer discussed the beginning of a new phase 3 trial for a peanut immunotherapy patch known as DBV712.

United States David Fleischer Immunology Center At Children Hospital Colorado Immunology Center Hospital Colorado Evaluate Safety Simplicity

Source: hcplive.com

David Fleischer, MD: Benefits of Immunotherapy Product, Hopes for Future of Treatment

April 17, 2023

In this interview segment, Fleischer further described some of the key points about the peanut immunotherapy patch, DBV712, and the product’s phase 3 VITESSE trial.

United States David Fleischder Drug Administration Immunology Center Evaluate Safety Simplicity Section Head

Source: hcplive.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Evaluate Safety Simplicity News Today

David Fleischer, MD: Phase 3 Trial on Peanut Immunotherapy Patch

David Fleischer, MD: Benefits of Immunotherapy Product, Hopes for Future of Treatment

Explore More Categories